Related Funds
Fund Name | Location |
080808 Capital | New York, New York, United States |
Accuron Technologies | Central Region, Singapore, Singapore |
Bader Sultan & Bros | - |
Binyou Network Technology | China, Shanghai |
Business Valley | Al Qahirah, Cairo, Egypt |
Chile Ventures | California, Menlo Park, United States |
Circuit Health | New York, New York, United States |
ConnectCapital | Bombay, India, Maharashtra |
DFW Capital | New Jersey, Teaneck, United States |
Droi | China, Shanghai, Xuhui |
Evolv Ventures | Chicago, Illinois, United States |
GENESIS Ventures | - |
InnoStar Venture | - |
Jim Simons | - |
Naftali Investments | - |
Razorback Capital | Kansas City, Missouri, United States |
Totem Investment | California, Rancho Santa Fe, United States |
Tsinghua Tongfang | Beijing, Beijing, China |
ZMV Associates | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Dot | $9M | 30 Mar 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Doctornow | $34M | 02 Jun 2022 | Seongnam, Kyonggi-do, South Korea | ||
Doctornow | $8M | 13 Oct 2021 | Seongnam, Kyonggi-do, South Korea | ||
Npixel | $87M | 31 Aug 2021 | South Korea, Gyeonggi-do, South Korea | ||
Newracle Genetics | $26M | 03 Jun 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
bepro11 | $10M | 11 Jun 2020 | Germany, Baden-Württemberg, Germany | ||
Npixel | $26M | 07 Jan 2020 | South Korea, Gyeonggi-do, South Korea | ||
$12M | 26 Mar 2019 | South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Dot | $9M | 30 Mar 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Doctornow | $34M | 02 Jun 2022 | Seongnam, Kyonggi-do, South Korea | ||
Doctornow | $8M | 13 Oct 2021 | Seongnam, Kyonggi-do, South Korea | ||
Npixel | $87M | 31 Aug 2021 | South Korea, Gyeonggi-do, South Korea | ||
Newracle Genetics | $26M | 03 Jun 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
bepro11 | $10M | 11 Jun 2020 | Germany, Baden-Württemberg, Germany | ||
Npixel | $26M | 07 Jan 2020 | South Korea, Gyeonggi-do, South Korea | ||
$12M | 26 Mar 2019 | South Korea |